Skip to main content

 Scientific publications

Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm.

Authors : Berghmans T, Dingemans AM, Hendriks LEL, Cadranel J
Year : 2020
Journal : Eur Respir J
Volume : 55

Current challenges in the management of nonsmall cell lung cancer brain metastases.

Authors : Hendriks LEL, Cadranel J, Berghmans T
Year : 2020
Journal : Eur Respir J
Volume : 55

Oligometastatic non-small cell lung cancer (NSCLC): Does number of metastasis matter?

Authors : Giaj-Levra N, Giaj Levra M, Berghmans T, Novello S, Hendriks LE, Levy A, Besse B, Dingemans AC
Year : 2020
Journal : Lung Cancer
Volume : 139
Pages : 216-218

EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease.

Authors : Levy A, Hendriks LEL, Berghmans T, Faivre-Finn C, GiajLevra M, GiajLevra N, Hasan B, Pochesci A, Girard N, Greillier L, Lantuéjoul S, Edwards J, OBrien M, Reck M, Besse B, Novello S, Dingemans AC
Year : 2019
Journal : Eur J Cancer
Volume : 122
Pages : 109-114

Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinion.

Authors : Hendriks LEL, Dooms C, Berghmans T, Novello S, Levy A, De Ruysscher D, Hasan B, Giaj Levra M, Giaj Levra N, Besse B, Vansteenkiste J, Dingemans AC
Year : 2019
Journal : Eur J Cancer
Volume : 123
Pages : 28-35

Current management of limited-stage SCLC and CONVERT trial impact: Results of the EORTC Lung Cancer Group survey.

Authors : Levy A, Hendriks LEL, Le Péchoux C, Falk S, Besse B, Novello S, Dingemans AC, Hasan B, Reck M, Berghmans T, Faivre-Finn C
Year : 2019
Journal : Lung Cancer
Volume : 136
Pages : 145-147

[Lung transplantation for lepidic invasive adenocarcinoma: From a clinical question to an ethical consideration].

Authors : Créquit P, Cadranel J, Mal H, Grigoriu B, Berghmans T
Year : 2019
Journal : Rev Mal Respir
Volume : 36
Pages : 919-923

Definition of Synchronous Oligometastatic Non-Small Cell Lung Cancer-A Consensus Report.

Authors : Dingemans AC, Hendriks LEL, Berghmans T, Levy A, Hasan B, Faivre-Finn C, Giaj-Levra M, Giaj-Levra N, Girard N, Greillier L, Lantuéjoul S, Edwards J, OBrien M, Reck M, Smit EF, van Schil P, Postmus PE, Ramella S, Lievens Y, Gaga M, Peled N, Scagliotti GV, Senan S, Paz-Ares L, Guckenberger M, McDonald F, Ekman S, Cufer T, Gietema H, Infante M, Dziadziuszko R, Peters S, Porta RR, Vansteenkiste J, Dooms C, De Ruysscher D, Besse B, Novello S
Year : 2019
Journal : J Thorac Oncol
Volume : 14
Pages : 2109-2119

SMAD4 Mutation in Small Cell Transformation of Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.

Authors : DHaene N, Le Mercier M, Salmon I, Mekinda Z, Remmelink M, Berghmans T
Year : 2019
Journal : Oncologist
Volume : 24
Pages : 9-13

Defining Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Systematic Review.

Authors : Giaj-Levra N, Giaj-Levra M, Durieux V, Novello S, Besse B, Hasan B, Hendriks LE, Levy A, Dingemans AC, Berghmans T
Year : 2019
Journal : J Thorac Oncol
Volume : 14
Pages : 2053-2061

[Lung cancer: Prognosis in intensive care depends mainly on the acute complication].

Authors : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Year : 2019
Journal : Rev Mal Respir
Volume : 36
Pages : 333-341

The Position of Inhaled Chemotherapy in the Care of Patients with Lung Tumors: Clinical Feasibility and Indications According to Recent Pharmaceutical Progresses.

Authors : Rosière R, Berghmans T, de Vuyst P, Amighi K, Wauthoz N
Year : 2019
Journal : Cancers (Basel)
Volume : 11

Immune checkpoint inhibitors (antibodies to PD1 and PD-L1), a new therapeutic weapon against non-small cell bronchial carcinoma.

Authors : Berghmans T, Grigoriu B, Sculier JP, Meert AP
Year : 2018
Journal : Rev Mal Respir
Volume : 35(2)
Pages : 197-205

Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cancer Group survey.

Authors : Levy A, Faivre-Finn C, Hasan B, De Maio E, Berghoff AS, Girard N, Greillier L, Lantuéjoul S, OBrien M, Reck M, Dingemans AC, Novello S, Berghmans T, Besse B, Hendriks L
Year : 2018
Journal : Eur J Cancer
Volume : 93
Pages : 37-46

Systemic treatments for thymoma and thymic carcinoma: A systematic review.

Authors : Berghmans T, Durieux V, Holbrechts S, Jungels C, Lafitte JJ, Meert AP, Moretti L, Ocak S, Roelandts M, Girard N
Year : 2018
Journal : Lung Cancer
Volume : 126
Pages : 25-31

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Authors : Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, van Schil P, Blum TG
Year : 2018
Journal : BMC Cancer
Volume : 18
Pages : 1144

Les patients ages de plus de 65 ans atteints d’un cancer admis aux soins intensifs.

Authors : Sirjacques C, Ameye L, Berghmans T, Paesmans M, Sculier JP, Meert AP
Year : 2018
Journal : Rev Med Brux
Volume : 39(6)
Pages : 487-494

Le mot du Rédac-Chef.

Authors : Berghmans T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 131

Une nouvelle étoile au firmament scientifique.

Authors : Berghmans T
Year : 2018
Journal : Rev Med Brux
Volume : 39
Pages : 68

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Authors : Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Schepereel A, Subotic DR, van Schil P, Blum TG
Year : 2018
Journal : Eur Respir J
Volume : 52